Forsyth Medical Center participating in Avastin trial for new glioblastoma patients
Winston-Salem, N.C. The Derrick L. Davis Forsyth Regional Cancer Center at Forsyth Medical Center is participating in a national trial of the experimental drug Avastin
to treat glioblastoma, a fast-growing tumor of the brain or spinal cord.
Forsyth Regional Cancer Center (FRCC) is participatin...
Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer
Sutent/Taxol Will Earn Decision Resources' Clinical Gold Standard Status for the Indication by 2012, According to a New Report from Decision Resources
WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and hea...
Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
Unmet Need for Efficacious Therapies for Treating Patients With Mutated KRAS Genes Presents Significant Opportunity for Drug Developers, According to a New Report from Decision Resources
WALTHAM, Mass., March 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advis...
Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme, According to a New Report from Decision Resources
WALTHAM, Mass., March 9 /PRNewswire/ -- Deci...
Genentech/Roche/Chugai's Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
Significant Unmet Need Remains for Agents that are Effective in
Treating Triple-Negative Beast Cancer, According to a New Report from
WALTHAM, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Off-Label Avastin Use for Wet Macular Degeneration
Treatment Could Save Millions Their Sight
PORTLAND, Ore., Feb. 25 /PRNewswire/ -- The Food and Drug
Administration (FDA) has only approved Avastin
for cancer of the colon and
lungs. In off-label use, however, Avastin
is proving itself as a "miracle
drug" that's currently used by...
FDA OKs Avastin for Advanced Breast Cancer
Drug has significant risks, experts say
FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration went against the recommendation of its own advisory panel on Friday and approved the cancer drug Avastin
for women with advanced breast cancer.
The agency cleared the d...
In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
Following its Approval, Erbitux Will Earn Gold-Standard Status in 2011, According to a New Report from Decision Resources
WALTHAM, Mass., Feb. 20 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms focusing on pharmaceutical and
Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
Seventy-nine Percent of U.S. Oncologists Currently Use Avastin
to Treat the Disease, According to a New Macroview Update from Decision Resources
WALTHAM, Mass., Feb. 11 /PRNewswire/ -- Decision Resources, Inc., one
of the world's leading research and advisory firms focusing on
Taxol with avastin produces noteworthy results
INDIANAPOLIS The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.
The study with Avastin
showed the biggest improvement in metastatic breas...
Avastin in Medical Technology
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
BASEL, Switzerland, Dec. 10 /PRNewswire/ -- New data being presented at
the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin
(bevacizumab) and oral Xeloda (capecitabine) continue
to offer new and better treatment options for breast cancer patients al...
Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
Despite Widespread Use, Formulary Coverage of Targeted Cancer Therapies is Inconsistent, According to a New Report from Decision Resources
WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- Data From Pivotal Phase III AVADO Study Presented at ASCO for the First Time
BASEL, Switzerland, May 31 /PRNewswire/ -- Avastin
significantly improves the time patients with metastatic breast cancer live
without their disease getting worse ("pro...
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced the
initiation of the INTORACT (INvestigation of TORISEL and Avastin
Combination Therapy) study, a worldwide randomized, open-label, phase 3b
study comparing TORISEL(R)...
Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon
- Tolerability is an Increasingly Important Factor When Selecting Treatment Options for Patients - ABSTRACT No: 5110 (Poster 6H)
BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the
largest oncology meeting in the world, the American Societ...
Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint
- Results of This Trial Further Confirm the Benefit Avastin
Brings to Patients With Breast Cancer.
BASEL, Switzerland, Feb. 13 /PRNewswire/ -- Roche announced today that
a phase III study in metastatic breast cancer investigating Avastin
(bevacizumab) in combination with ...
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Roche in collaboration with Genentech commit to large phase III adjuvant clinical programme set to unlock Avastin's potential in early breast
SAN ANTONIO, Dec. 17 /PRNewswire/ -- According to new phase II study
(bevacizumab) can proceed to be tested after breast cancer
Wyeth's Torisel and Roche/Genentech's Avastin Will Challenge Pfizer's Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
Increased Survival Rates and Decreased Disease Progression Rates Are the Advantages, According to a New Report from Decision Resources
WALTHAM, Mass., Aug. 7 /PRNewswire/ -- Decision Resources, Inc., one of
the world's leading research and advisory firms focusing on pharmaceutical
FDA MedWatch: Avastin (bevacizumab) and Formation of
Tracheoesophageal Fistula in a Recent Clinical Study in Patients
with Limited-stage Small Cell Lung Cancer
ROCKVILLE, Md., April 21, 2007-Genentech and FDA notified
healthcare professionals of important new safety information
regarding tracheoesophageal (TE) fistula formation in a recent
clinical study in patients with limited-stage small cell lung
cancer (SCLC). This multicenter, non-randomized, singl...
Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer
EAGAN, Minn.--(BUSINESS WIRE)--Jun 4, 2007 - Imprime PGG(TM), an
investigational new drug from Biothera that enhances the innate
immune system response, increases the effectiveness of Avastin(R)
(bevacizumab) to kill cancer cells, according to new preclinical
research presented yesterday at the 200...
Avastin in Medical Dictionary
... discuss whether chemicals in our environment have a connection to the risk of breast cancer. ... Common Treatments for Breast Cancer. Arimidex. avastin
... You may sometimes doubt your ability to successfully breast - feed. It is common to have questions and occasional struggles. Remember, mos...
Avastin in Biological News
A crystal ball for brain cancer?
... and predict which ones will be shrunk by the drug avastin
-- before the patient ever starts treatment. By l.... Food and Drug Administration approved the use of avastin
last month for the treatment of brain cancer. The...ents, like McNabb, are most likely to benefit from avastin
before starting a single dose of treatment. The f...
Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
...VEGF signaling from inside the cell.
About 5 percent of patients taking avastin
develop blood clot-related side effects, Iruela-Arispe said. But because avastin
was approved only three years ago, it is unclear what side effects may occu...
Tiny Tampa Bay fish key to evolution of immune system
...ceptible to enzymes that break them down. A number of such monoclonal antibody-based drugs are in clinical use, such as Herceptin for breast cancer or avastin
for colorectal cancer.
The lancelet's immune response proteins, however, are resilient. Understanding their essential architecture with such precis...
Scientists discover genetic pathway responsible for breast cancer cell growth
...d to positive clinical results," says Dr. Joseph Ragaz, Director of MUHC Oncology Program. "Evidence-based data on agents such as Gleevac in leukemia, avastin
in colorectal cancer, and more recently with Herceptin for breast cancer, confirm that the efforts of researchers like Dr. Giguere and his team save l...
UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
...CLA research, including Gleevec and the breast cancer drug Herceptin. Additionally, UCLA scientists played key roles in testing the targeted therapies avastin
UCLA also is the only public university in California to boast a sophisticated Good Manufacturing Practice (GMP) suite, a specialized ...
Avastin in Biological Technology
Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
...man breast cancer. r84 is distinctive because it selectively blocks VEGF from binding to VEGF receptor 2 (VEGFR2), while non-selective agents such as avastin
block binding to both VEGFR2 and VEGF receptor 1 (VEGFR1). Selective anti-VEGF agents such as r84 may have safety and efficacy advantages over non-se...
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
...nths and one-year
survival rates of 33% to 43%. Market approval for avastin
paclitaxel and carboplatin chemotherapy for NSCLC was based on...h paclitaxel and carboplatin
chemotherapy alone. Survival rates for avastin
versus chemotherapy alone were reported as 51% ve...
Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
... However, Off-Label Use of avastin
Will Take Market Share Away from Lucentis from 2012 to 2017, According to a...ics' Lucentis in Europe. However, off-label use of Genentech/Roche/Chugai's avastin
will take market share away from Lucentis from 2012 through 2017 in the Uni...
OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
... survival rates of 33% to 43%. Market approval for avastin
plus paclitaxel and carboplatin chemotherapy for N...reated with chemotherapy alone. Survival rates for avastin
plus chemotherapy versus chemotherapy alone were r...dy compares favorably to the survival reported for avastin
plus paclitaxel and carboplatin chemotherapy," sai...
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
...an Avastin, the current leader in this therapeutic area. A new approach is needed because of increasing data-supported concerns about the high cost of avastin
relative to the limited increase in the lifespan of patients gained with its use."
Company Profile : AngioGenex, Inc. is actively engaged in th...
Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
Used in Combination with Taxol and Paraplatin Will... expert
opinion show that Roche/Genentech/Chugai's avastin
(bevacizumab) plus the
regimen of paclitaxel (Bris...atients with
advanced ovarian cancer. As a result, avastin
will earn a 22 percent...
Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
views as of any subsequent date. Rosetta does not assume any obligation to
update any forward-looking statements unless required by law.
(TM), a registered trademark of Genentech, Inc
Media Rachel Spielman T: +1-212-583-2714 E: firstname.lastname@example.org
Biotech Drops Amid Tough Markets in February
...vado, a Phase III study
evaluating its cancer drug avastin
in combination with docetaxel
chemotherapy, met it...sponsored Avado
study investigated the addition of avastin
administered in two different
dosages in combination with chemotherapy. Both doses of avastin
combination with chemotherapy showed "statistic...
Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
... 23,605 11,099
Total liabilities and shareholders' equity 26,038 $ 13,243
is a registered trademark of Genentech, Inc.
Contact: Media Rachel Spielman T: +1-212-583-2714 E: email@example.com
Investors Ron Ka...
Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists
...ectly to compounding pharmacies as of January 1.
is commonly administered by retinal specialists an... quality.
"Many retinal specialists consider the avastin
treatment option as an
indispensable part of their...continue to meet the critical and ongoing need for avastin
ophthalmologic practice. Unlike other firms, we...